The microenvironment in colorectal cancer: An integrative histopathological, transcriptomic and metabolomic approach
Abstract
Colorectal tumours with high stromal content have a poor prognosis. In part 1, I investigated, at the protein and gene expression levels, the composition of these tumours in comparison to stroma-low tumours. In part 2, KRAS mutant colorectal cancer cell lines had a different metabolism compared to KRAS wild type after inhibition of mTORC1. This may contribute to therapeutic resistance.
Colorectal cancerGalectin-1Fibroblast activation proteinTumour stromaTumour-stroma ratioKRAS mutationAspartateConsensus molecular subtypes (CMS)

